Velasquez v. Secretary of Health and Human Services

In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

No. 25-616V

AMBERLEE VELASQUEZ, Chief Special Master Corcoran

Petitioner,

v. Filed: April 29, 2026

SECRETARY OF HEALTH AND

HUMAN SERVICES,

Respondent.

John Robert Howie, Howie Law P.C., Dallas, TX, for Petitioner.

Irene Angelica Firippis, U.S. Department of Justice, Washington, DC, for Respondent.

RULING ON ENTITLEMENT1

On April 9, 2025, Amberlee Velasquez filed a petition for compensation under the

National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the

“Vaccine Act”). Petitioner alleges that she suffered a left shoulder injury related to vaccine

administration (“SIRVA”) following her receipt of an influenza (“flu”) vaccine on December

12, 2023. Petition, ECF No. 1 at Preamble. The case was assigned to the Special

Processing Unit of the Office of Special Masters (the “SPU”). ECF No. 11.

1 Because this unpublished opinion contains a reasoned explanation for the action in this case, I am

required to post it on the United States Court of Federal Claims' website in accordance with the E-

Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic

Government Services). This means the opinion will be available to anyone with access to the internet.

In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or

other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon

review, I agree that the identified material fits within this definition, I will redact such material from public

access.

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease

of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §

300aa (2012).

For the reasons set forth below, I find that Petitioner more likely than not suffered

the onset of shoulder pain within 48 hours after her vaccination, and that she has satisfied

all other requirements for a Table SIRVA claim. Therefore, Petitioner is entitled to

compensation under the Vaccine Act.

I. Relevant Procedural History

The claim was assigned to SPU in May 2025. Three months later, in August 2025,

Respondent requested suspension of the deadline for his Rule 4(c) Report (which would

set forth his formal position regarding entitlement of the claim) to permit the parties to

explore settlement. ECF No. 14. Rather than conveying a settlement demand, however,

Petitioner filed a Motion for a Fact Ruling on Onset on November 19, 2025, ECF No. 18

(“Motion”) (arguing that Respondent had informally questioned Petitioner’s onset

showing, but the evidence was “conclusive” in her favor, and formal resolution of this fact

would properly move the case into formal damages phase). After briefly exploring litigative

risk settlement, in December 2025 the parties reported an impasse and agreed to finish

briefing entitlement. ECF No. 19-23.

Respondent filed a combined Rule 4(c) Report and Response on Feb. 9, 2026,

ECF No. 24 (“Response”) (recommending dismissal of the Table SIRVA claim on the

grounds that Petitioner had not preponderantly established onset). Petitioner filed a Reply

that same day, ECF No. 25. The matter is ripe for adjudication.

II. Authority

Before compensation can be awarded under the Vaccine Act, a petitioner must

demonstrate, by a preponderance of evidence, all matters required under Section

11(c)(1), including the factual circumstances surrounding his claim. Section 13(a)(1)(A).

In making this determination, the special master or court should consider the record as a

whole. Section 13(a)(1). A petitioner’s allegations must be supported by medical records

or by medical opinion. Id.

To resolve factual issues, the special master must weigh the evidence presented,

which may include contemporaneous medical records and testimony. See Burns v. Sec'y

of Health & Hum. Servs., 3 F.3d 415, 417 (Fed. Cir. 1993) (explaining that a special

master must decide what weight to give evidence including oral testimony and

contemporaneous medical records). Contemporaneous medical records are presumed to

be accurate. See Cucuras v. Sec’y of Health & Hum. Servs., 993 F.2d 1525, 1528 (Fed.

Cir. 1993). To overcome the presumptive accuracy of medical records testimony, a

petitioner may present testimony which is “consistent, clear, cogent, and compelling.”

Sanchez v. Sec'y of Health & Hum. Servs., No. 11–685V, 2013 WL 1880825, at *3 (Fed.

2

Cl. Spec. Mstr. Apr. 10, 2013) (citing Blutstein v. Sec'y of Health & Hum. Servs., No. 90–

2808V, 1998 WL 408611, at *5 (Fed. Cl. Spec. Mstr. June 30, 1998)).

In addition to requirements concerning the vaccination received, the duration and

severity of a petitioner’s injury, and the lack of other award or settlement,3 a petitioner

must establish that he or she suffered an injury meeting the Table criteria, in which case

causation is presumed, or an injury shown to be caused-in-fact by the vaccination she

received. Section 11(c)(1)(C).

The most recent version of the Table, which can be found at 42 C.F.R. § 100.3,

identifies the vaccines covered under the Program, the corresponding injuries, and the

time period in which the particular injuries must occur after vaccination. Section 14(a).

Pursuant to the Vaccine Injury Table, a SIRVA is compensable if it manifests within 48

hours of the administration of certain covered vaccines. 42 C.F.R. § 100.3(a). The criteria

establishing a SIRVA under the accompanying QAI are as follows:

Shoulder injury related to vaccine administration (SIRVA). SIRVA manifests

as shoulder pain and limited range of motion occurring after the

administration of a vaccine intended for intramuscular administration in the

upper arm. These symptoms are thought to occur as a result of unintended

injection of vaccine antigen or trauma from the needle into and around the

underlying bursa of the shoulder resulting in an inflammatory reaction.

SIRVA is caused by an injury to the musculoskeletal structures of the

shoulder (e.g., tendons, ligaments, bursae, etc.). SIRVA is not a

neurological injury and abnormalities on neurological examination or nerve

conduction studies (NCS) and/or electromyographic (EMG) studies would

not support SIRVA as a diagnosis (even if the condition causing the

neurological abnormality is not known). A vaccine recipient shall be

considered to have suffered SIRVA if such recipient manifests all of the

following:

(i) No history of pain, inflammation or dysfunction of the affected shoulder

prior to intramuscular vaccine administration that would explain the alleged

signs, symptoms, examination findings, and/or diagnostic studies occurring

after vaccine injection;

(ii) Pain occurs within the specified time frame;

3 In summary, a petitioner must establish the receipt of a vaccine covered by the Program, administered

either in the United States and its territories – or in another geographical area but qualifying for a limited

exception; that the injury or its residual effects lasted for more than six months, resulted in inpatient

hospitalization and surgical intervention, or resulted in death; and the lack of a civil suit, award, or settlement

for the injury. See Section 11(c)(1).

3

(iii) Pain and reduced range of motion are limited to the shoulder in which

the intramuscular vaccine was administered; and

(iv) No other condition or abnormality is present that would explain the

patient’s symptoms (e.g., NCS/EMG or clinical evidence of radiculopathy,

brachial neuritis, mononeuropathies, or any other neuropathy).

42 C.F.R. § 100.3(c)(10).

A special master may find that the first symptom or manifestation of onset of an

injury occurred “within the time period described in the Vaccine Injury Table even though

the occurrence of such symptom or manifestation was not recorded or was incorrectly

recorded as having occurred outside such period.” Section 13(b)(2). “Such a finding may

be made only upon demonstration by a preponderance of the evidence that the onset [of

the injury] . . . did in fact occur within the time period described in the Vaccine Injury

Table.” Id.

III. Findings of Fact and Conclusions of Law - Onset

I have reviewed all of the filings submitted by both parties to date, but now focus

on the evidence most relevant to the solely disputed issue: the onset of Petitioner’s left

shoulder pain relative to vaccination.

x Petitioner was born in 1975. Shad no history of left shoulder pain or dysfunction,

or any other medical conditions relevant to the present onset dispute. Response

at 2; see also e.g., Ex. 3 at 87-92 (primary care record three months pre-

vaccination).

x Petitioner received the at-issue vaccine in her left deltoid, during a primary care

encounter on December 12, 2023. Ex. 3 at 93-97.

x Twenty-nine (29) days later, on January 10, 2024, Petitioner returned to the

primary care practice for initial evaluation of “left shoulder pain… start[ing] after

she received the influenza vaccination on December 12, 2023.” Ex. 3 at 101

(emphasis added). She denied any previous issues with immunizations, any

injuries or other possible triggers for the pain, or any history of left shoulder

problems. Id. The primary care nurse practitioner also assessed that Petitioner had

“left shoulder pain going on for about a month after she received the

influenza vaccination,” for which he offered naproxen, prednisone, and home

exercises. Id. at 102 (emphasis added).

4

x On January 24, 2024, the primary care nurse practitioner memorialized in a record

that Petitioner was still experiencing “left shoulder pain going on for about 1.5

mo[nths] after she received the influenza vaccination,” which warranted an

MRI and an orthopedics consult. Ex. 3 at 106-07 (emphasis added).

x At a February 21, 2024 orthopedics initial evaluation, Petitioner reported “left

shoulder pain… beg[inning] after she received a flu vaccine on 12/12/2023” with

“continued pain at the proximal lateral aspect of her arm in the area of the

injection since that time.” Ex. 3 at 111 (emphasis added). The symptoms were

“relatively constant and worsened with increased use of the shoulder.” Id.

(emphasis added). She again denied any trauma. Id. The orthopedist assessed

“left shoulder pain 10 weeks post receiving a flu vaccine at the left proximal

lateral arm.” Id. (emphasis added).

x The March 7, 2024 MRI report’s indication was “pain in left shoulder since flu

shot.” Ex. 4 at 12 (emphasis added). The radiologist reviewing the images

commented: “This all may be a result of the previous intramuscular shot.

Depending on the timeframe since the injection, a[n] inflammatory or

infectious process should be considered.” Ex. 4 at 12; Ex. 3 at 118 (emphasis

added).

x At a March 11, 2024 follow-up, the orthopedist reiterated that Petitioner had “[l]eft

shoulder 13 weeks status post receiving a flu vaccine at the left proximal

lateral arm…” Ex. 3 at 118 (emphasis added). In light of Petitioner’s “persistent

left shoulder pain after flu vaccination 12/12/23,” she was referred to another

orthopedics practice for further evaluation. Id. (emphasis added).

x On March 21, 2024, upon establishing care at the new orthopedics practice,

Petitioner reported “receiv[ing] her flu shot on December 12, 2023, [in] her

upper deltoid and began noticing anterior lateral shoulder pain in the left

shoulder ever since.” Ex. 8 at 14 (emphasis added). She again “denie[d] any

specific trauma.” Id. She received a steroid injection and was referred to formal

physical therapy (“PT”). Id.

x At an April 3, 2024 initial PT evaluation, Petitioner reported that her left shoulder

pain began on “12/12/23… She received a flu shot [that day] and… through

the day she had pain/soreness… [T]he pain has never really resolved and…

is constant with intermittent spikes based on activity… [Petitioner] denie[d]

any prior injuries to the left shoulder. [Petitioner] receives yearly flu shot and

reports no prior issues…” Ex. 9 at 3 (emphasis added). The physical therapist

assessed “signs and symptoms of SIRVA s/p the flu vaccine on 12/12/2023.”

Id. at 4 (emphasis added).

5

x On April 24, 2024, a rheumatologist (treating Petitioner for unrelated issues)

recorded her history of “chronic left shoulder pain” after receiving a flu shot

“too proximal in the arm.” Ex. 5 at 23 (emphasis added).

x A May 9, 2024 primary care record (again focused on other issues) noted that

Petitioner was planning to undergo surgery to remedy “left shoulder pain caused

by a flu shot back in December” and she had been “dealing with this pain for

quite some time.” Ex. 3 at 122 (emphasis added); see also Ex. 11 at 6-8 (June

19, 2024 arthroscopic surgery report – not specifically addressing onset).

x The records of post-surgical PT (dating from June 28 – October 25, 2024) continue

to reflect the injury’s initial onset as “12/12/23 after receiving flu shot.” See e.g.,

Ex. 12 at 5 (emphasis added).4

x In a declaration signed April 2, 2025, Petitioner stated that she had previously been

in her “usual good state of health.” Ex. 1 at ¶ 3. “At the time the [December 12,

2023] vaccination was administered, she did not experience any unusual

effects; however, within 34 hours of [her] vaccination, [she] experienced an

aching pain and stiffness in [her] left shoulder… that felt like being hit with

a sledgehammer.” Id. at ¶ 4 (emphasis added). The pain worsened over the

following days – limiting her ROM, daily activities, and sleep. Id. Petitioner

“initially believed the pain [she] was experiencing was going to resolve on

its own with time; however, as [her] pain persisted and was worsening, [she]

decided to schedule an evaluation with [her] primary care” which occurred

just 29 days post-vaccination, on January 10, 2024. Id. at ¶¶ 4-5 (emphasis

added).

Preponderant evidence supports the determination that Petitioner developed new

left shoulder pain within 48 hours after her vaccination – consistent with the Table SIRVA

element. As reflected above, Petitioner sought medical evaluation for a new left shoulder

injury (which she believed was causally related to her December 12, 2023 vaccination) in

less than a month after vaccination. That timing is consistent with Petitioner’s explanation

that she initially hoped that the injury would self-resolve, and that she waited for an

appointment at her established primary care practice. Ex. 1 at ¶¶ 4-5; see also Motion at

5-6 (arguing that this initial treatment “delay” is not unreasonable, and has been accepted

in past SIRVA cases) (internal citations omitted).

4 The direct records of Petitioner’s arthroscopic surgery on June 19, 2024 (Ex. 11 at 6-8), and her post-

operative orthopedic follow-ups through December 30, 2024 (Ex. 13 at 11) do not address the left shoulder

injury’s onset.

6

Petitioner’s histories began contemporaneously to the events at issue (and

remained consistent over time), and they were intended to advance accurate medical

diagnosis and treatment, and therefore “warrant consideration as trustworthy evidence.”

Cucuras, 993 F.2d 1525, 1528 (Fed. Cir. 1993). There are no intervening medical

encounters suggesting the absence of a shoulder injury shortly after vaccination. Motion

at 6-8 (internal citations omitted).

Petitioner’s pain was often described in terms that are temporally nonspecific, like

“after,” “since,” “ever since,” or “status post” (s/p) the vaccination. See e.g., Ex. 3 at 101,

102, 106, 111, 118; Ex. 4 at 12; Ex. 8 at 14; Ex. 9 at 3, 4. But such statements are

“generally understood by the special masters to mean very close in time – immediately,

or at most within a day or two” especially in the SIRVA onset context. Motion at 8-9, citing

Flowers v. Secy’ of Health & Hum. Servs., No. 20-285V, 2024 WL 2828211, at *11 (Fed.

Cl. Spec. Mstr. May 8, 2024) (internal parentheticals andd citations omitted), mot. for rev.

den’d, 173 Fed. Cl. 613 (2024).

Moreover, certain medical records are even more specific, and set forth

timeframes that clearly fall within the Table-defined onset period. Motion at 9-11; see e.g.,

Ex. 3 at 102 (January 10, 2024 primary care record describing pain “going on for about a

month”); id. at 106 (January 24, 2024 primary care record of pain “going on for about 1.5

months”); Ex. 9 at 4 (April 3, 2024 PT record of pain starting the day of vaccination, and

specifically on December 12, 2023).

No evidence suggests an alternative, off-Table timeframe. Motion at 10. And there

is “no requirement that a Petitioner seek formal medical care within 48 hours of

vaccination in order to establish SIRVA onset.” Id. at 10-11 (internal citations omitted);

accord Response at 6 n. 3 (Respondent’s agreement that such prompt medical attention

is not required by the Table).

For all of those reasons, Respondent’s assessment that Petitioner’s

contemporaneous medical records are too “unclear” or “vague” to fulfill the Table SIRVA

onset requirement is not persuasive. Response at 6-7 and n. 3. And this case lacks

several of the deficiencies in Respondent’s cited case. Response at 7, citing Laird v. Sec’y

of Health & Hum. Servs., No. 19-682V, 2023 WL 7104782 at *3-4 (Fed. Cl. Spec. Mstr.

Aug. 30, 2023) (reflecting a primary care encounter one month post-vaccination but not

documenting shoulder complaints; a five-month initial treatment delay regarding the

shoulder; and one notation that the pain began “10 days after her flu shot” – specifically

contradicting the Table SIRVA claim).

7

IV. Remaining Table SIRVA QAI Criteria and Statutory Requirements

Respondent concedes that Petitioner “has satisfied the other Table criteria for

SIRVA.” Response at 6, n. 2. I find that those requirements have been preponderantly

satisfied. In particular, the December 12, 2023 vaccine was administered into her left

deltoid muscle. Ex. 3 at 96. She developed new range of motion; her symptoms were

limited to the left shoulder; and they were not explained by another condition or

abnormality. See e.g., Ex. 3 at 111-12; Ex. 4 at 9, 12; Ex. 8 at 13-14; Ex. 9 at 3-4; Ex. 11

at 6-8.

The statutory requirements applicable to all claims are also preponderantly

established. Petitioner received a covered vaccine in the United States. Ex. 3 at 96. She

experienced residual effects of the injury for more than six months. See e.g., Ex. 3 at 111-

12; Ex. 4 at 9, 12; Ex. 8 at 13-14; Ex. 9 at 3-4; Ex. 11 at 6-8. And she states that she has

not received any type of award, judgment, or settlement for this injury. Ex. 1 at ¶ 34.

Conclusion

Petitioner’s Motion at ECF No. 18 is hereby GRANTED. Petitioner is entitled to

Vaccine Program compensation for a Table SIRVA. A separate damages order will issue.

IT IS SO ORDERED.

s/Brian H. Corcoran

Brian H. Corcoran

Chief Special Master

8